Back to Company Profile
Alpha

Alpha Profiles · Company Profile

VERTEX PHARMACEUTICALS INC / MA

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/vertex-pharmaceuticals-inc-ma

Vertex Pharmaceuticals logo
Entity
Public listing published
Primary listing
NASDAQ: VRTX
Verification
Partially verified
Last reviewed
2026-09-13T04:45:02.867545+00:00

Overview

Alpha's canonical identity and public leadership record for Vertex Pharmaceuticals.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

10 public records
AK
Amit K. Sachdev, J.D.

Executive Vice President, Chief Patient and External Affairs Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
VRTX executive roster sourceMay 3, 2026
Charles F. Wagner, Jr. portrait
Charles F. Wagner, Jr.

Executive Vice President, Chief Operating and Financial Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
VRTX executive roster sourceMay 3, 2026
Craig B. Thompson, M.D. portrait
Craig B. Thompson, M.D.

Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
VRTX executive roster sourceMay 3, 2026
DJ
Duncan J. McKechnie

Executive Vice President, Chief Commercial Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
VRTX executive roster sourceMay 3, 2026
EM
E. Morrow Morrey Atkinson, III, Ph.D.

Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
VRTX executive roster sourceMay 3, 2026
JB
Jonathan Biller, J.D.

Executive Vice President, Chief Legal Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
VRTX executive roster sourceMay 3, 2026
KC
Kristen C. Ambrose, CPA

Senior Vice President, Chief Accounting Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
VRTX executive roster sourceMay 3, 2026
MB
Mark Bunnage, D.Phil

Executive Vice President, Chief Scientific Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
VRTX executive roster sourceMay 3, 2026
ON
Ourania Nia Tatsis, Ph.D.

Executive Vice President, Chief Regulatory and Quality Officer

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
VRTX executive roster sourceMay 3, 2026
RK
Reshma Kewalramani, M.D.

Chief Executive Officer and President

State
confirmed
Effective
Date not stated
Confidence
94%
Evidence
VRTX executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

11 public records

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-09-13T04:45:02.867545+00:00

VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)

Supports Official website

Reviewed 2026-08-29T22:19:43Z

Generated 2026-09-13T08:10:54.038Z

Data as of 2026-09-13T04:45:02.867545+00:00

https://registry.alpha.ac/companies/vertex-pharmaceuticals-inc-ma